MACROGENICS INC (MGNX) Stock Analyst Ratings
USA - NASDAQ:MGNX - US5560991094 - Common Stock
1.58 USD
-0.08 (-4.82%)
1.57 USD
-0.01 (-0.63%)
ChartMill assigns a Buy % Consensus number of 75% to MGNX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.47. This target is 119.49% above the current price.
MGNX was analyzed by 13 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about MGNX.
In the previous month the buy percentage consensus was at a similar level.
MGNX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-03 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-08-15 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-05-20 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2025-05-14 | Stifel | Maintains | Hold -> Hold |
| 2025-05-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-03-25 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-11-07 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-18 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-21 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-15 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-07 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-08-01 | BTIG | Downgrade | Buy -> Neutral |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-07-31 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-07-31 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-07-31 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2024-07-31 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-05-24 | BTIG | Maintains | Buy -> Buy |
| 2024-05-13 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-05-10 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-05-10 | BMO Capital | Downgrade | Outperform -> Market Perform |
| 2024-05-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-10 | Stifel | Downgrade | Buy -> Hold |
| 2024-05-10 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-09 | TD Cowen | Upgrade | Hold -> Buy |
| 2024-04-04 | JMP Securities | Reiterate | Market Outperform |
| 2024-03-11 | JMP Securities | Maintains | Outperform -> Outperform |
| 2024-03-11 | Citigroup | Maintains | Buy -> Buy |
MACROGENICS INC / MGNX FAQ
What do analysts expect the price target to be for MACROGENICS INC (MGNX)?
13 analysts have analysed MGNX and the average price target is 3.47 USD. This implies a price increase of 119.49% is expected in the next year compared to the current price of 1.58.
Can you provide the consensus rating for MACROGENICS INC stock?
The consensus rating for MACROGENICS INC (MGNX) is 75.3846 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover MACROGENICS INC (MGNX) stock?
The number of analysts covering MACROGENICS INC (MGNX) is 13.